-
Views
-
Cite
Cite
Marianne Schmid, Hellmut Samonigg, Herbert Stoger, Herbert Auer, Manfred H. Sternthal, Martie Wilders-Truschnig, Emil C. Reisinger, Use of Interferon γ and Mebendazole to Stop the Progression of Alveolar Hydatid Disease: Case Report, Clinical Infectious Diseases, Volume 20, Issue 6, June 1995, Pages 1543–1546, https://doi.org/10.1093/clinids/20.6.1543
- Share Icon Share
Abstract
We describe a 28-year-old female who presented with metastatic spread of a suspected occult tumor. The diagnosis of alveolar echinococcosis was established by needle biopsy of the liver and ELISA. The patient's clinical symptoms initially decreased after treatment with mebendazole, but the lesions progressed during the following 6 months. Albendazole was not available in Austria. Because the synthesis of interferon γ (IFN-γ) and IFN-α is markedly decreased in patients with echinococcosis, we treated our patient with IFN-γ while continuing mebendazole therapy. This combination halted progression of the disease during the 12 months of follow-up.